Investment Centers of America’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-13,426
Closed -$363K 553
2016
Q2
$363K Buy
13,426
+56
+0.4% +$1.54K 0.04% 318
2016
Q1
$364K Buy
13,370
+1,668
+14% +$44.7K 0.04% 323
2015
Q4
$338K Sell
11,702
-1,688
-13% -$46.7K 0.04% 316
2015
Q3
$365K Buy
13,390
+1,088
+9% +$30.8K 0.06% 285
2015
Q2
$337K Buy
12,302
+198
+2% +$5.57K 0.05% 307
2015
Q1
$324K Sell
12,104
-2,140
-15% -$49.3K 0.05% 322
2014
Q4
$303K Buy
14,244
+1,832
+15% +$40.9K 0.07% 285
2014
Q3
$296K Buy
12,412
+2,650
+27% +$61K 0.05% 308
2014
Q2
$226K Buy
+9,762
New +$216K 0.05% 293

Other funds holding NVO

Investment Centers of America's NVO Position: Q3 2016 in Review

Investment Centers of America sold out of Novo Nordisk (NVO) in Q3 2016, closing a stake of 13,426 shares — an estimated $363K sold.

Investment Centers of America first reported a position in NVO in Q2 2014 and held it in 9 quarters. The position peaked at $365K in Q3 2015. 512 funds tracked by Wall St. Rank hold NVO as of Q3 2016.

  • Investment Centers of America reported no remaining Novo Nordisk position as of Q3 2016 after selling out during the quarter.
  • Investment Centers of America sold 13,426 Novo Nordisk shares in Q3 2016, an estimated $363K.
  • Investment Centers of America first reported a position in Novo Nordisk in Q2 2014 and held it in 9 quarters.
  • Investment Centers of America's Novo Nordisk position peaked at $365K in Q3 2015.
  • 512 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2016.

Based on Investment Centers of America's 13F filing for Q3 2016, filed 10 Nov 2016.